Continuing Education
THE MONTANA DENTAL ASSOCIATION
PRESENTS
WHAT'S NEW IN DENTAL PHARMACOTHERAPY
KAREN A . BAKER, MS
Friday - September 17, 2010
7 CE Hours
8:00 am - Registration
8:30 am to 5 pm - Class
Butte War Bonnet Hotel
2100 Cornell Ave.
Butte MT 59701
800/443-1806 • 406/494-7800
About the Clinician
Professor Karen A. Baker has been on the Dental College faculty at the University of Iowa for 28 years and occupies a unique role in dental practice and education. She is a clinical pharmacist with a Master’s degree in clinical pharmacology and therapeutics and is focused on patient-specific dental drug therapy She has given over 800 programs nationally and internationally and holds memberships in many dental and clinical pharmacology and therapeutics organizations. Ms. Baker is on the editorial board of the Journal of the Academy of General Dentistry. Her dental education-based pharmacy and drug therapy consultation center is the only one in the United States. She has authored more than 50 articles and abstracts and lectures extensively in pre-doctoral and graduate-level courses at the University of Iowa.
About the Course
The range of drug therapy options available to dental practitioners has greatly expanded over the past ten years. This expansion has opened the door to unprecedented therapeutic successes as well as disastrous drug misadventures. This course will update the dental team on recent developments in dental pharmacotherapy while providing strategies for prescribing to ensure therapeutic success. Drug therapy and alternative medicine reference sources will be listed and critiqued as to usefulness in daily practice. Clinically relevant information about effectiveness, adverse effects, patient specific drug selection criteria, dosing, and cost will be presented for therapeutic agents commonly used in dentistry. Systemic antibiotics, analgesics, and mucosal disease agents will be evaluated and discussed. Special attention will be given to certain controversial areas including antibiotic premedication of patient conditions not specified in the current AHA guidelines. Potentially dangerous drug interactions important in clinical dentis try will be listed and reviewed with emphasis on avoidance and patient management strategies. Extensive and very current handouts will be provided to maximize the chairside value of this fast-paced and entertaining course.
Objectives
Upon completion of the course and reviewing the handouts, the participants should be able to:
- buy and easily use the best drug and alternative medicine references for dental practice,
- choose the most cost effective antibiotic for a specific patient,
- prescribe antibiotic premedication for certain patients with a variety of implants and conditions based on screening criteria and current evidence,
- prescribe innovative topical and systemic therapies for both inflammatory and infectious mucositis patients,
- choose an analgesic NSAID or COX-2 inhibitor based on relative adverse effects, drug interactions, efficacy for pain vs inflammation, and cost, and
- enhance the analgesic effects of opiod analgesics while minimizing their adverse effects.
Register Online
Brochure and Registration (pdf)
Montana Dental Association
17 ½ S. Last Chance Gulch
P.O. Box 1154
Helena, Montana 59624
E-Mail: mda@mt.net
800-257-4988 (In Montana only)
406-443-2061 (in the Helena area)
Fax: 406-443-1546